08/14/2024
Bedell Cristin team advise on proposed $550 million acquisition of Ironshore Therapeutics Inc
Ironshore Therapeutics Inc – a long-standing client of Bedell Cristin – has reached a definitive agreement to be acquired by Nasdaq-listed Collegium as part of its strategic growth into neurology.